Building on a Legacy of Research
The Research We’ve Helped Fund
Before the Brave Ronil Foundation, our founders spent years funding pediatric brain cancer research. Together, that work directed $463,900 to eight research projects at some of the world’s leading medical institutions.
The Brave Ronil Foundation is a new, independent 501(c)(3) organization and does not claim these accomplishments as its own. We share them to show the experience and commitment we build on.
A Timeline of Impact
Year by year, project by project
Mapping DMG Response and Resistance to Therapy
Drs. Aaron Diaz & Javad Nazarian
UCSF & University Children’s Hospital Zürich
Cell-Free DNA Whole-Genome Sequencing for DMG Clinical Trials
Dr. Sabine Mueller & Dr. Sebastian Waszak
UCSF & Centre for Molecular Medicine Norway
AI for Volumetric Assessment of DMG MRIs
Dr. Sabine Mueller, Dr. Andreas Rauschecker, Dr. Sarah Brüningk & Dr. Benjamin Kann
UCSF, University of Bern & Dana-Farber Cancer Institute
De-risking Discovery: Unlocking Safe Targets for DMG Therapies
Dr. John Prensner
University of Michigan Medical School
mRNA Reprogramming of Tumor-Associated Macrophages for DMG
Dr. Ernest Moles
Children’s Cancer Institute & University of New South Wales
Cell-to-Cell Interactions in DIPG After GD2-CAR-T
Dr. Embla Steiner Malka & Dr. Michelle Monje
Stanford University
Tree-House Initiative
Dr. Olena Vaske
UC Santa Cruz
Gut Microbiome in DMG Treatment Response
Dr. Sabine Mueller, Dr. Jasper van der Lugt & Dr. Cassie Kline
UCSF, Princess Máxima Center & Children’s Hospital of Philadelphia
This is the foundation we build on.
As the Brave Ronil Foundation, our mission is to carry this work forward — funding the next generation of DIPG and pediatric brain cancer research, and standing beside the families who need it most. The legacy above is where we started. What comes next is what your support makes possible.
Brave Ronil Foundation · 501(c)(3) · EIN 41-4603375